|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Johnson DH, Schiller JH and Bunn PA Jr:
Recent clinical advances in lung cancer management. J Clin Oncol.
32:973–982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Howlader NNA, Krapcho M, Garshell J,
Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,
Mariotto A, et al: SEER cancer statistics review, 1975–2012.
National Cancer Institute; Bethesda MD: 2015
|
|
5
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern
Cooperative Oncology Group, : Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fleming RJ: Structural conservation of
Notch receptors and ligands. Semin Cell Dev Biol. 9:599–607. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kageyama R and Ohtsuka T: The Notch-Hes
pathway in mammalian neural development. Cell Res. 9:179–188. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hori K, Sen A and Artavanis-Tsakonas S:
Notch signaling at a glance. J Cell Sci. 126:2135–2140. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zagouras P, Stifani S, Blaumueller CM,
Carcangiu ML and Artavanis-Tsakonas S: Alterations in Notch
signaling in neoplastic lesions of the human cervix. Proc Natl Acad
Sci USA. 92:pp. 6414–6418. 1995; View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dang TP, Gazdar AF, Virmani AK, Sepetavec
T, Hande KR, Minna JD, Roberts JR and Carbone DP: Chromosome 19
translocation, overexpression of Notch3, and human lung cancer. J
Natl Cancer Inst. 92:1355–1357. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Santagata S, Demichelis F, Riva A,
Varambally S, Hofer MD, Kutok JL, Kim R, Tang J, Montie JE,
Chinnaiyan AM, et al: JAGGED1 expression is associated with
prostate cancer metastasis and recurrence. Cancer Res.
64:6854–6857. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grabher C, von Boehmer H and Look AT:
Notch 1 activation in the molecular pathogenesis of T-cell acute
lymphoblastic leukaemia. Nat Rev Cancer. 6:347–359. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roy M, Pear WS and Aster JC: The
multifaceted role of Notch in cancer. Curr Opin Genet Dev.
17:52–59. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ye YZ, Zhang ZH, Fan XY, Xu XL, Chen ML,
Chang BW and Zhang YB: Notch3 overexpression associates with poor
prognosis in human non-small-cell lung cancer. Med Oncol.
30:5952013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Westhoff B, Colaluca IN, D'Ario G,
Donzelli M, Tosoni D, Volorio S, Pelosi G, Spaggiari L, Mazzarol G,
Viale G, et al: Alterations of the Notch pathway in lung cancer.
Proc Natl Acad Sci USA. 106:pp. 22293–22298. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Donnem T, Andersen S, Al-Shibli K, Al-Saad
S, Busund LT and Bremnes RM: Prognostic impact of Notch ligands and
receptors in nonsmall cell lung cancer: Coexpression of Notch-1 and
vascular endothelial growth factor-A predicts poor survival.
Cancer. 116:5676–5685. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Burns JA, Cheney CA, Zhang N,
Vitelli S, Wang F, Bett A, Chastain M, Audoly LP and Zhang ZQ:
Distinct expression profiles of Notch-1 protein in human solid
tumors: Implications for development of targeted therapeutic
monoclonal antibodies. Biologics. 4:163–171. 2010.PubMed/NCBI
|
|
18
|
Andersen S, Donnem T, Al-Saad S, Al-Shibli
K, Stenvold H, Busund LT and Bremnes RM: Correlation and
coexpression of HIFs and NOTCH markers in NSCLC. Anticancer Res.
31:1603–1606. 2011.PubMed/NCBI
|
|
19
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee SM, Jung CK, Ko YH, Choi JY, Lee KY
and Kang CS: Expression of Notch 1 and 3 is related to inhibition
of lymph node metastasis and progression in non-small cell lung
carcinomas. Basic Appl Pathol. 1:93–97. 2008. View Article : Google Scholar
|
|
21
|
Yuan X, Wu H, Xu H, Han N, Chu Q, Yu S,
Chen Y and Wu K: Meta-analysis reveals the correlation of Notch
signaling with non-small cell lung cancer progression and
prognosis. Sci Rep. 5:103382015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu R, Wei S, Chen J and Xu S: Mesenchymal
stem cells in lung cancer tumor microenvironment: Their biological
properties, influence on tumor growth and therapeutic implications.
Cancer Lett. 353:145–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang J, Song H, Liu B, Yu B, Wang R and
Chen L: Expression of Notch-1 and its clinical significance in
different histological subtypes of human lung adenocarcinoma. J Exp
Clin Cancer Res. 32:842013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nguyen D, Rubinstein L, Takebe N, Miele L,
Tomaszewski JE, Ivy P, Doroshow JH and Yang SX: Notch1 phenotype
and clinical stage progression in non-small cell lung cancer. J
Hematol Oncol. 8:92015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Osanyingbemi-Obidi J, Dobromilskaya I,
Illei PB, Hann CL and Rudin CM: Notch signaling contributes to lung
cancer clonogenic capacity in vitro but may be circumvented in
tumorigenesis in vivo. Mol Cancer Res. 9:1746–1754. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Maraver A, Fernández-Marcos PJ, Herranz D,
Muñoz-Martin M, Gomez-Lopez G, Cañamero M, Mulero F, Megías D,
Sanchez-Carbayo M, Shen J, et al: Therapeutic effect of γ-secretase
inhibition in KrasG12V-driven non-small cell lung carcinoma by
derepression of DUSP1 and inhibition of ERK. Cancer Cell.
22:222–234. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Allen TD, Rodriguez EM, Jones KD and
Bishop JM: Activated Notch1 induces lung adenomas in mice and
cooperates with Myc in the generation of lung adenocarcinoma.
Cancer Res. 71:6010–6018. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Licciulli S, Avila JL, Hanlon L, Troutman
S, Cesaroni M, Kota S, Keith B, Simon MC, Puré E, Radtke F, et al:
Notch1 is required for Kras-induced lung adenocarcinoma and
controls tumor cell survival via p53. Cancer Res. 73:5974–5984.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Baumgart A, Mazur PK, Anton M, Rudelius M,
Schwamborn K, Feuchtinger A, Behnke K, Walch A, Braren R, Peschel
C, et al: Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven
murine non-small cell lung cancer model. Oncogene. 34:578–588.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen Y, De Marco MA, Graziani I, Gazdar
AF, Strack PR, Miele L and Bocchetta M: Oxygen concentration
determines the biological effects of NOTCH-1 signaling in
adenocarcinoma of the lung. Cancer Res. 67:7954–7959. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wael H, Yoshida R, Kudoh S, Hasegawa K,
Niimori-Kita K and Ito T: Notch1 signaling controls cell
proliferation, apoptosis and differentiation in lung carcinoma.
Lung Cancer. 85:131–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ji X, Wang Z, Geamanu A, Sarkar FH and
Gupta SV: Inhibition of cell growth and induction of apoptosis in
non-small cell lung cancer cells by delta-tocotrienol is associated
with notch-1 down-regulation. J Cell Biochem. 112:2773–2783. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ji X, Wang Z, Geamanu A, Goja A, Sarkar FH
and Gupta SV: Delta-tocotrienol suppresses Notch-1 pathway by
upregulating miR-34a in nonsmall cell lung cancer cells. Int J
Cancer. 131:2668–2677. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Eliasz S, Liang SY, De Marco MA, Machek O,
Skucha S, Miele L and Bocchetta M: Notch1 stimulates survival of
lung adenocarcinoma cells during hypoxia by activating the IGF-1R
pathway. Oncogene. 29:2488–2498. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen Y, Li D, Liu H, Xu H, Zheng H, Qian
F, Li W, Zhao C, Wang Z and Wang X: Notch-1 signaling facilitates
survivin expression in human non-small cell lung cancer cells.
Cancer Biol Ther. 11:14–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ding XY, Ding J, Wu K, Wen W, Liu C, Yan
HX, Chen C, Wang S, Tang H, Gao CK, et al: Cross-talk between
endothelial cells and tumor via delta-like ligand 4/Notch/PTEN
signaling inhibits lung cancer growth. Oncogene. 31:2899–2906.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Haruki N, Kawaguchi KS, Eichenberger S,
Massion PP, Olson S, Gonzalez A, Carbone DP and Dang TP:
Dominant-negative Notch3 receptor inhibits mitogen-activated
protein kinase pathway and the growth of human lung cancers. Cancer
Res. 65:3555–3561. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Konishi J, Kawaguchi KS, Vo H, Haruki N,
Gonzalez A, Carbone DP and Dang TP: Gamma-secretase inhibitor
prevents Notch3 activation and reduces proliferation in human lung
cancers. Cancer Res. 67:8051–8057. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin L, Mernaugh R, Yi F, Blum D, Carbone
DP and Dang TP: Targeting specific regions of the Notch3
ligand-binding domain induces apoptosis and inhibits tumor growth
in lung cancer. Cancer Res. 70:632–638. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Konishi J, Yi F, Chen X, Vo H, Carbone DP
and Dang TP: Notch3 cooperates with the EGFR pathway to modulate
apoptosis through the induction of bim. Oncogene. 29:589–596. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li C, Zhang S, Lu Y, Zhang Y, Wang E and
Cui Z: The roles of Notch3 on the cell proliferation and apoptosis
induced by CHIR99021 in NSCLC cell lines: A functional link between
Wnt and Notch signaling pathways. PLoS One. 8:e846592013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Salnikov AV, Gladkich J, Moldenhauer G,
Volm M, Mattern J and Herr I: CD133 is indicative for a resistance
phenotype but does not represent a prognostic marker for survival
of non-small cell lung cancer patients. Int J Cancer. 126:950–958.
2010.PubMed/NCBI
|
|
44
|
Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT,
Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, et al: Cisplatin selects
for multidrug-resistant CD133+ cells in lung adenocarcinoma by
activating Notch signaling. Cancer Res. 73:406–416. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xie M, He CS, Wei SH and Zhang L: Notch-1
contributes to epidermal growth factor receptor tyrosine kinase
inhibitor acquired resistance in non-small cell lung cancer in
vitro and in vivo. Eur J Cancer. 49:3559–3572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yuan X, Wu H, Han N, Xu H, Chu Q, Yu S,
Chen Y and Wu K: Notch signaling and EMT in non-small cell lung
cancer: Biological significance and therapeutic application. J
Hematol Oncol. 7:872014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shi C, Qian J, Ma M, Zhang Y and Han B:
Notch 3 Protein, not its gene polymorphism, is associated with the
chemotherapy response and prognosis of advanced NSCLC patients.
Cell Physiol Biochem. 34:743–752. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mizugaki H, Sakakibara-Konishi J, Ikezawa
Y, Kikuchi J, Kikuchi E, Oizumi S, Dang TP and Nishimura M:
γ-Secretase inhibitor enhances antitumour effect of radiation in
Notch-expressing lung cancer. Br J Cancer. 106:1953–1959. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kang J, Kim E, Kim W, Seong KM, Youn H,
Kim JW, Kim J and Youn B: Rhamnetin and cirsiliol induce
radiosensitization and inhibition of epithelial-mesenchymal
transition (EMT) by miR-34a-mediated suppression of Notch-1
expression in non-small cell lung cancer cell lines. J Biol Chem.
288:27343–27357. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Theys J, Yahyanejad S, Habets R, Span P,
Dubois L, Paesmans K, Cleutjens J, Groot AJ, Schuurbiers OCJ,
Lambin P, et al: High NOTCH activity induces radiation resistance
in non small cell lung cancer. Radiother Oncol. 108:440–445. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Takebe N, Nguyen D and Yang SX: Targeting
notch signaling pathway in cancer: Clinical development advances
and challenges. Pharmacol Ther. 141:140–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S,
Wu GS and Wu K: Notch signaling: An emerging therapeutic target for
cancer treatment. Cancer Lett. 369:20–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Rahman M, Deleyrolle L, Vedam-Mai V, Azari
H, Abd-El-Barr M and Reynolds BA: The cancer stem cell hypothesis:
Failures and pitfalls. Neurosurgery. 68:531–545. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:pp.
3983–3988. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
58
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra
D, Zhou J, Claypool K, et al: Highly purified CD44+
prostate cancer cells from xenograft human tumors are enriched in
tumorigenic and metastatic progenitor cells. Oncogene.
25:1696–1708. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Jiang F, Qiu Q, Khanna A, Todd NW, Xing L,
Wang H, Liu Z, Su Y, Stass S and Katz RL: Aldehyde dehydrogenase 1
is a tumor stem cell-associated marker in lung cancer. Mol Cancer
Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Eyler CE and Rich JN: Survival of the
fittest: Cancer stem cells in therapeutic resistance and
angiogenesis. J Clin Oncol. 26:2839–2845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association
of reactive oxygen species levels and radioresistance in cancer
stem cells. Nature. 458:780–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Berns A: Stem cells for lung cancer? Cell.
121:811–813. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Kim CF, Jackson EL, Woolfenden AE,
Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT and Jacks T:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Huntly BJ and Gilliland DG: Leukaemia stem
cells and the evolution of cancer-stem-cell research. Nat Rev
Cancer. 5:311–321. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Krivtsov AV, Twomey D, Feng Z, Stubbs MC,
Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, et al:
Transformation from committed progenitor to leukaemia stem cell
initiated by MLL-AF9. Nature. 442:818–822. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Mathieu J, Zhang Z, Zhou W, Wang AJ,
Heddleston JM, Pinna CM, Hubaud A, Stadler B, Choi M, Bar M, et al:
HIF induces human embryonic stem cell markers in cancer cells.
Cancer Res. 71:4640–4652. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sullivan JP, Spinola M, Dodge M, Raso MG,
Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, et
al: Aldehyde dehydrogenase activity selects for lung adenocarcinoma
stem cells dependent on notch signaling. Cancer Res. 70:9937–9948.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Hassan KA, Wang L, Korkaya H, Chen G,
Maillard I, Beer DG, Kalemkerian GP and Wicha MS: Notch pathway
activity identifies cells with cancer stem cell-like properties and
correlates with worse survival in lung adenocarcinoma. Clin Cancer
Res. 19:1972–1980. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zheng Y, de la Cruz CC, Sayles LC,
Alleyne-Chin C, Vaka D, Knaak TD, Bigos M, Xu Y, Hoang CD, Shrager
JB, et al: A rare population of CD24(+)ITGB4(+)Notch(hi) cells
drives tumor propagation in NSCLC and requires Notch3 for
self-renewal. Cancer Cell. 24:59–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
